Home/Pipeline/CompStor Novos Secondary Analysis

CompStor Novos Secondary Analysis

Genomic Variant Calling

CommercialActive

Key Facts

Indication
Genomic Variant Calling
Phase
Commercial
Status
Active
Company

About OmniTier

Founded in 2018 and headquartered in San Francisco, OmniTier is a private computational biology company focused on delivering affordable, on-premise genomic analysis solutions. Its core technology leverages memory-centric computing and AI to accelerate and improve the accuracy of variant calling and interpretation, targeting clinical diagnostics and research. The company offers standalone appliances, such as the CompStor series, which aim to reduce analysis costs and time while maintaining data security and control for its customers.

View full company profile